MR classification of renal masses with pathologic correlation

European Radiology

Volumn 18, Issue 2, 2008, Pages 365-375

  Pedrosa, Ivan ^a   Chou, Mary T ^a   Ngo, Long ^a   Baroni, Ronaldo H ^a   Genega, Elizabeth M ^a   Galaburda, Laura ^a   DeWolf, William C ^a   Rofsky, Neil M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Carcinoma; Kidney neoplasms; Magnetic resonance imaging; Multivariate analysis; Renal cell

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER SIZE; CLEAR CELL CARCINOMA; CLINICAL FEATURE; COLLATERAL CIRCULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; KIDNEY CANCER; KIDNEY VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLARY CARCINOMA; PREDICTION; PRIORITY JOURNAL; RETROPERITONEUM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; KIDNEY; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK; SENSITIVITY AND SPECIFICITY;

EID: 39049096185     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-007-0757-0     Document Type: Article

References (41)

1. Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203-205
2. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738-745
3. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS (2005) Renal cell carcinoma 2005: New frontiers in staging, prognostication and targeted molecular therapy. J Urol 173:1853-1862
4. Stadler WM (2005) Targeted agents for the treatment of advanced renal cell carcinoma. Cancer 104:2323-2333
5. Kaelin WG Jr (2004) The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 10:6290S-6295S
6. Hecht EM, Israel GM, Krinsky GA et al (2004) Renal masses: Quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 232:373-378
7. Rofsky NM, Bosniak MA (1997) MR imaging in the evaluation of small (< or =3.0 cm) renal masses. Magn Reson Imaging Clin N Am 5:67-81
8. Rominger MB, Kenney PJ, Morgan DE, Bernreuter WK, Listinsky JJ (1992) Gadolinium-enhanced MR imaging of renal masses. Radiographics 12:1097-1116; discussion 1117-1098
9. Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll PR (1991) Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 178:803-809
10. Semelka RC, Shoenut JP, Magro CM, Kroeker MA, MacMahon R, Greenberg HM (1993) Renal cancer staging: Comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging. J Magn Reson Imaging 3:597-602
11. Ho VB, Allen SF, Hood MN, Choyke PL (2002) Renal masses: Quantitative assessment of enhancement with dynamic MR imaging. Radiology 224:695-700
12. Bosniak MA (1986) The current radiological approach to renal cysts. Radiology 158:1-10
13. Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN (1988) CT diagnosis of renal angiomyolipoma: The importance of detecting small amounts of fat. AJR Am J Roentgenol 151:497-501
14. Eilenberg SS, Lee JK, Brown J, Mirowitz SA, Tartar VM (1990) Renal masses: Evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Radiology 176:333-338
15. Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: Comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231:365-371
16. Semelka RC, Shoenut JP, Kroeker MA, MacMahon RG, Greenberg HM (1992) Renal lesions: Controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques [see comments]. Radiology 182:425-430
17. Yoshimitsu K, Honda H, Kuroiwa T et al (1999) MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient-echo imaging. J Magn Reson Imaging 9:579-585
18. Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D (2007) MR Imaging of papillary renal neoplasms: Potential application for characterization of small renal masses. Eur Radiol 17:193-200
19. Yoshimitsu K, Irie H, Tajima T et al (2004) MR imaging of renal cell carcinoma: Its role in determining cell type. Radiat Med 22:371-376
20. Earls J, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: Optimization with a test examination and a power injector. Radiology 202:268-273
21. Israel GM, Hindman N, Hecht E, Krinsky G (2005) The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 184:1868-1872
22. Zhang J, Pedrosa I, Rofsky NM (2003) MR techniques for renal imaging. Radiol Clin North Am 41:877-907
23. Agresti A, Coull B (1998) Approximate is better than "exact" for interval estimation of binomial proportions. American Statistician 119-126
24. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature. J Urol 175:425-431
25. Kouba E, Smith A, McRackan D, Wallen EM, Pruthi RS (2007) Watchful waiting for solid renal masses: Insight into the natural history and results of delayed intervention. J Urol 177:466-470
26. Guinan P, Frank W, Saffrin R, Rubenstein M (1994) Staging and survival of patients with renal cell carcinoma. Semin Surg Oncol 10:47-50
27. Kuczyk M, Wegener G, Merseburger AS et al (2005) Impact of tumor size on the long-term survival of patients with early stage renal cell cancer. World J Urol 23:50-54
28. Leibovich BC, Pantuck AJ, Bui MH et al (2003) Current staging of renal cell carcinoma. Urol Clin North Am 30:481-497, viii
29. Han KR, Janzen NK, McWhorter VC et al (2004) Cystic renal cell carcinoma: Biology and clinical behavior. Urol Oncol 22:410-414
30. Mejean A, Hopirtean V, Bazin JP et al (2003) Prognostic factors for the survival of patients with papillary renal cell carcinoma: Meaning of histological typing and multifocality. J Urol 170:764-767
31. Herts BR, Coll DM, Novick AC et al (2002) Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 178:367-372
32. Turner KJ, Moore JW, Jones A et al (2002) Expression of hypoxia-inducible factors in human renal cancer: Relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62:2957-2961
33. Djordjevic G, Mozetic V, Mozetic DV et al (2007) Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma. Pathol Res Pract 203:99-106
34. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612-624
35. Semenza GL (2000) HIF-1 and human disease: One highly involved factor. Genes Dev 14:1983-1991
36. Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG (1997) Lipid in renal clear cell carcinoma: Detection on opposed-phase gradient-echo MR images. Radiology 205:103-107
37. Storkel S, Eble JN, Adlakha K et al (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:987-989
38. Kim JK, Kim SH, Jang YJ et al (2006) Renal angiomyolipoma with minimal fat: Differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239:174-180
39. Milner J, McNeil B, Alioto J et al (2006) Fat poor renal angiomyolipoma: patient, computerized tomography and histological findings. J Urol 176:905-909
40. Korobkin M, Lombardi TJ, Aisen AM et al (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197:411-418
41. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S (1995) Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: Observer performance versus quantitative measures. AJR Am J Roentgenol 165:91-95